Xceleron (Chapter 11)

Analytics
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals

14C AMS analytical tech & clinical design - R&D efficiency - translational science, target turnover, preclinical, Phase 0, enriched Phase I & Phase II/III

Suggest edits

Founded

1997

Raised

$10M

Follow us

Companies in the same industry

AnaBios Corporation
PharmaFluidics
RxAdvance
G-CON
VG Life Sciences
Mycodev Group
Outpost Medicine
Oragenics
Leukos Biotech
laboratoire MédiS

Alexa global traffic share

Index

By TNW

Xceleron (Chapter 11)

Xceleron (Chapter 11)